Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Muscle edema of the lower limb determined by MRI in Asian hypokalaemic periodic paralysis patients. 25213595 2015
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Genotype and phenotype analysis of patients with sporadic periodic paralysis. 21841462 2012
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR A calcium channel mutant mouse model of hypokalemic periodic paralysis. 23187123 2012
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 Biomarker phenotype GENOMICS_ENGLAND The role of CACNA1S in predisposition to malignant hyperthermia. 19825159 2009
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks. 19225109 2009
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Myopathy as the first symptom of hypokalemic periodic paralysis--case report of a girl from a Polish family with CACNA1S (R1239G) mutation. 18229654 2007
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis. 18162704 2007
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family. 17418573 2007
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G). 15716625 2005
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. 15726306 2005
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Muscle weakness in a Japanese family of Arg1239His mutation hypokalemic periodic paralysis. 11555352 2001
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR [A case of familial hypokalemic periodic paralysis with hyperuricemia during paralytic attack and genetic analysis of the pedigree]. 11808349 2001
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Muscle fiber conduction velocity in arg1239his mutation in hypokalemic periodic paralysis. 10639629 2000
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Clinical-molecular study of a family with essential tremor, late onset seizures and periodic paralysis. 11034874 2000
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H. 9852570 1998
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor alpha1 subunits (R528H) 9512357 1998
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. 9066893 1997
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 GeneticVariation phenotype UNIPROT Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. 9199552 1997
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells. 8605978 1996
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. 7847370 1995
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR A calcium channel mutation causing hypokalemic periodic paralysis. 7987325 1994
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 CausalMutation phenotype CLINVAR Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. 8004673 1994
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 Biomarker phenotype GENOMICS_ENGLAND
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 SusceptibilityMutation phenotype CLINVAR
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
0.600 GeneticVariation phenotype CLINVAR